These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6114934)

  • 1. A controlled trial of oxypertine in tardive dyskinesia.
    Freeman HL; Soni SD; Carpenter L
    Int Pharmacopsychiatry; 1980; 15(5):281-91. PubMed ID: 6114934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxypertine in tardive dyskinesia: an 8-week controlled study.
    Soni SD; Freeman HL; Hussein EM
    Br J Psychiatry; 1984 Jan; 144():48-52. PubMed ID: 6140973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxypertine for tardive dyskinesia.
    Freeman H; Soni SD
    Br J Psychiatry; 1980 May; 136():522-3. PubMed ID: 6104524
    [No Abstract]   [Full Text] [Related]  

  • 4. Oxypertine in tardive dyskinesia: a long-term controlled study.
    Soni SD; Freeman HL; Bamrah JS; Sampath G
    Acta Psychiatr Scand; 1986 Nov; 74(5):446-50. PubMed ID: 2880458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxypertine in tardive dyskinesia.
    O'Shea B; Falvey J
    Ir Med J; 1985 Jul; 78(7):202-3. PubMed ID: 2863234
    [No Abstract]   [Full Text] [Related]  

  • 6. CSF monoamine metabolism in patients with tardive dyskinesia: effect of oxypertine and hydroxyzine pamoate.
    Akiyama K; Nagao T; Yamamoto M; Fujimoto A; Ebara T; Sato M; Otsuki S
    Folia Psychiatr Neurol Jpn; 1983; 37(2):129-35. PubMed ID: 6200411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of tardive dyskinesia with oxypertine--preliminary clinical experience and a brief review of the literature.
    Kazamatsuri H
    Compr Psychiatry; 1980; 21(5):352-7. PubMed ID: 6106539
    [No Abstract]   [Full Text] [Related]  

  • 8. Oxypertine in tardive dyskinesia.
    Youssef HA
    Ir Med J; 1985 Nov; 78(11):340. PubMed ID: 2867066
    [No Abstract]   [Full Text] [Related]  

  • 9. Tardive dyskinesia and neurotransmitters: effects of sodium valproate, cyproheptadine, oxypertine, hydroxyzine pamoate and Ca-hopantenate on monoamine metabolites, cyclic nucleotides and gamma-aminobutyric acid in human cerebrospinal fluid.
    Ogawa T; Nagao T; Kashiwabara K; Fujiwara Y; Harada T; Otsuki S
    Clin Ther; 1984; 7 Spec No():1-17. PubMed ID: 6085032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin E in the treatment of tardive dyskinesia: a double-blind placebo-controlled study.
    Shriqui CL; Bradwejn J; Annable L; Jones BD
    Am J Psychiatry; 1992 Mar; 149(3):391-3. PubMed ID: 1346951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacies of agents related to GABA, dopamine, and acetylcholine in the treatment of tardive dyskinesia [proceedings].
    Chien C; Jung K; Ross-Townsend A
    Psychopharmacol Bull; 1978 Apr; 14(2):20-2. PubMed ID: 26102
    [No Abstract]   [Full Text] [Related]  

  • 12. Sulpiride in tardive dyskinesia.
    Casey DE; Gerlach J; Simmelsgaard H
    Psychopharmacology (Berl); 1979; 66(1):73-7. PubMed ID: 44375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-dergocrine (hydergine) in the treatment of tardive dyskinesia.
    Rastogi SC; Blowers AJ; Gibson AC
    Psychol Med; 1982 May; 12(2):427-9. PubMed ID: 6124989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baclofen in tardive dyskinesia patients maintained on neuroleptics.
    Stewart RM; Rollins J; Beckham B; Roffman M
    Clin Neuropharmacol; 1982 Dec; 5(4):365-73. PubMed ID: 6130838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.
    Bai YM; Yu SC; Lin CC
    J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of tardive dyskinesia with galantamine: a randomized controlled crossover trial.
    Caroff SN; Walker P; Campbell C; Lorry A; Petro C; Lynch K; Gallop R
    J Clin Psychiatry; 2007 Mar; 68(3):410-5. PubMed ID: 17388711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic measures in tardive dyskinesia].
    Tegeler J; Wöller W
    Fortschr Neurol Psychiatr; 1983 Jun; 51(6):203-26. PubMed ID: 6136457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of tardive dyskinesia with vitamin E.
    Egan MF; Hyde TM; Albers GW; Elkashef A; Alexander RC; Reeve A; Blum A; Saenz RE; Wyatt RJ
    Am J Psychiatry; 1992 Jun; 149(6):773-7. PubMed ID: 1350428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin E in the treatment of tardive dyskinesia.
    Elkashef AM; Ruskin PE; Bacher N; Barrett D
    Am J Psychiatry; 1990 Apr; 147(4):505-6. PubMed ID: 1969247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxypertine in combination with imipramine: a controlled trial.
    Sim M; Gordon EB; Nicol CG
    J Int Med Res; 1978; 6(1):4-10. PubMed ID: 23973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.